LOGIN  |  REGISTER
Assertio

Recent Insider Transactions - Lineage Cell Therapeutics (NYSEAMEX: LCTX)

Follow NYSEAMEX:LCTX Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NYSEAMEX LCTX Lineage Cell Therapeutics
Bradsher Neal C / director, 10 percent owner:
07/01/2025
Buy
$0.90
75,000
$67K
75,000
NYSEAMEX LCTX Lineage Cell Therapeutics
Amin Dipti / director
07/01/2025
Buy
$0.90
75,000
$67K
75,000
NYSEAMEX LCTX Lineage Cell Therapeutics
Jayasuriya Anula / director
07/01/2025
Buy
$0.90
75,000
$67K
75,000
NYSEAMEX LCTX Lineage Cell Therapeutics
Russell Angus C. / director
07/01/2025
Buy
$0.90
75,000
$67K
75,000
NYSEAMEX LCTX Lineage Cell Therapeutics
Mulroy Michael H. / director
07/01/2025
Buy
$0.90
75,000
$67K
75,000
NYSEAMEX LCTX Lineage Cell Therapeutics
ANDREWS DEBORAH J / director
07/01/2025
Buy
$0.90
75,000
$67K
75,000

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous